Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Boeing Co (BA) vs Incyte Corporation (INCY) Price & Performance

Incyte CorporationTrade

Price performance (Past 24H)

Key statistics

Boeing Co vs Incyte Corporation — how do they compare? Boeing Co trades at $233.93 (market cap $184.35B), while Incyte Corporation trades at $120.45 (market cap $24.54B). The key difference: Boeing Co is far larger — about 7.5× Incyte Corporation's market cap, and Boeing Co pays a 0.03% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.

BAINCY
Market Cap
$184.35B$24.54B
Volume
7,591,579
Sector
IndustrialsHealth
52-Week High
$252.15$129.93
52-Week Low
$179.12$81.61
Enterprise Value
$210.23B$20.04B
Dividend Yield
0.03%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Boeing Co

The Boeing Company, together with its subsidiaries, develops, produces, and markets commercial jet aircraft, as well as provides related support services to the commercial airline industry worldwide. The Company also researches, develops, produces, modifies, and supports information, space, and defense systems, including military aircraft, helicopters and space and missile systems.

Read more on BA

About Incyte Corporation

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.

Read more on INCY